Cita APA

Ribera Santasusana, J. M., Morgades, M., Garcia-Calduch, O., Sirvent, M., Buendia, B., Cervera, M., & Abrisqueta, P. (2024). Feasibility and outcomes after dose reduction of immunochemotherapy in young adults with Burkitt lymphoma and leukemia: Results of the BURKIMAB14 trial.

Citación estilo Chicago

Ribera Santasusana, Josep Maria, Mireia Morgades, Olga Garcia-Calduch, Maialen Sirvent, Buenaventura Buendia, Marta Cervera, y Pau Abrisqueta. Feasibility and Outcomes After Dose Reduction of Immunochemotherapy in Young Adults With Burkitt Lymphoma and Leukemia: Results of the BURKIMAB14 Trial. 2024.

Cita MLA

Ribera Santasusana, Josep Maria, et al. Feasibility and Outcomes After Dose Reduction of Immunochemotherapy in Young Adults With Burkitt Lymphoma and Leukemia: Results of the BURKIMAB14 Trial. 2024.